Dermatology · Beachwood, OH
NPI
1043875057
Since 2019
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3737 Park East Dr Ste 109
Beachwood, OH, 44122
Phone (216) 464-7333
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
9,272 services
Medicare patients, 2024
417
Average age 74
Drug cost, 2024
$175K
673 prescriptions
Company payments, 2025
$2,459
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah Gabros was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 7,001 times for 32 patients. In total Sarah Gabros billed 9,272 services in 52 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 7,001 | 32 | $1.32 | $9,225 |
| 17003 Destruction Skin Lesion | Office | 644 | 120 | $4.51 | $2,903 |
| 99213 Office E&M - Established | Office | 448 | 316 | $56.41 | $25K |
| 17000 Destruction Skin Lesion | Office | 219 | 164 | $32.78 | $7,178 |
| 17110 Destruction Skin Lesion | Office | 182 | 140 | $71.09 | $13K |
| 11102 Skin Biopsy | Office | 173 | 140 | $54.03 | $9,348 |
| 99214 Office E&M - Established | Office | 89 | 75 | $87.99 | $7,831 |
| 11103 Skin Biopsy | Office | 54 | 37 | $34.58 | $1,867 |
| 99212 Office E&M - Established | Office | 51 | 44 | $39.59 | $2,019 |
| 99203 Office E&M - New | Office | 49 | 49 | $56.36 | $2,761 |
| 96574 Skin | Office | 47 | 38 | $175.63 | $8,255 |
| 11104 Skin Biopsy | Office | 22 | 20 | $78.94 | $1,737 |
| 17004 Destruction Skin Lesion | Office | 19 | 18 | $113.10 | $2,149 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 19 | 18 | $0.71 | $13.51 |
| 17260 Destruction Skin Lesion | Office | 19 | 14 | $62.58 | $1,189 |
By year: 2023 $101K for 2,800 services; 2024 $115K for 9,272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah Gabros prescribed most often to Medicare patients was Ketoconazole, with 162 prescriptions and refills. In total Sarah Gabros wrote 673 Medicare prescriptions that cost $175K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 162 | 171 | 100 | $2,251 |
| Triamcinolone Acetonide Generic | 68 | 72 | 64 | $666 |
| Clobetasol Propionate Generic | 67 | 67 | 56 | $2,306 |
| Hydrocortisone Generic | 58 | 60 | 48 | $337 |
| Minoxidil Generic | 52 | 94 | 21 | $215 |
| Mupirocin Generic | 48 | 52 | 42 | $319 |
| Fluorouracil Generic | 17 | 17 | 14 | $1,177 |
| Valacyclovir Valacyclovir Hcl | 17 | 17 | 15 | $178 |
| Clindamycin Phosphate Generic | 16 | 17 | 16 | $463 |
| Tacrolimus Generic | 14 | 14 | 13 | $1,947 |
| Doxycycline Hyclate Generic | 13 | 13 | 11 | $160 |
| Claravis Isotretinoin | 12 | 12 | Under 11 | $609 |
Brand drugs: 34 claims; generic drugs: 639 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah Gabros $2,459 ($2,459 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $330.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $330 |
| Janssen Biotech, Inc. JNJ | 17 | $319 |
| Pfizer Inc. PFE | 23 | $294 |
| UCB, Inc. UCB.BR | 14 | $246 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 11 | $169 |
| Arcutis Biotherapeutics, Inc. ARQT | 22 | $169 |
| Regeneron Healthcare Solutions, Inc. REGN | 12 | $167 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $144 |
| Lilly USA, LLC LLY | 7 | $138 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $84.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.